• Machine Learning Uncovers New Senolytics for Cancer Research

  2026-04-22

  This article examines a recent study leveraging machine learning to identify novel senolytic compounds by screening published data, significantly reducing drug discovery costs. The findings have important implications for targeting senescent cells in cancer and aging research, and are compared with established approaches and resources for EGFR and ErbB2 inhibition.

• Simvastatin Induces Autophagy and Inhibits Prostate Tumor Gr

  2026-04-22

  This study demonstrates that Simvastatin, a cholesterol-lowering agent, robustly induces autophagy and suppresses proliferation in multiple prostate cancer cell lines. The findings illuminate a potential mechanism—autophagy-associated cell death—offering new directions for therapeutic strategies in castration-resistant prostate cancer.

• Perphenazine as Dopamine D2 Receptor Antagonist: Applied Wor

  2026-04-21

  Perphenazine stands out in neuropharmacology as a dopamine D2 receptor antagonist with versatile applications, from mitochondrial cell death induction to host-directed antibacterial strategies. This guide details robust experimental workflows, troubleshooting insights, and the latest cross-domain advances for Perphenazine-powered research.

• Hydrocortisone in Advanced Stress and Neuroprotection Resear

  2026-04-21

  Explore how hydrocortisone, a key glucocorticoid hormone, advances our understanding of stress response mechanisms and neuroprotection. This article delivers new scientific insight and protocol guidance for researchers seeking to harness hydrocortisone in complex disease models.

• Weight Loss Restores Intestinal Stretch-Induced Satiety in O

  2026-04-20

  This study demonstrates that intestinal stretch acutely suppresses food intake and improves glucose tolerance via mechanisms independent of GLP-1 signaling, but these effects are diminished in obesity. Both dietary and surgical weight loss restore the ability of intestinal stretch to regulate feeding and glucose homeostasis, highlighting plasticity in neural and metabolic pathways controlling satiety.

• Cinoxacin: Quinolone Antibiotic Workflows for Gram-Negative

  2026-04-20

  Cinoxacin stands out as a robust quinolone antibiotic for Gram-negative bacterial workflows, delivering reproducible inhibition of DNA synthesis and facilitating advanced urinary tract infection research. This guide integrates protocol precision, troubleshooting, and real-world comparative insights, positioning APExBIO’s Cinoxacin as a cornerstone for antimicrobial and resistance studies.

• Ruxolitinib Phosphate Induces Apoptosis and Pyroptosis in AT

  2026-04-19

  A recent study demonstrates that Ruxolitinib phosphate (INCB018424) induces both apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma (ATC) by inhibiting DRP1-dependent mitochondrial fission through JAK1/2-STAT3 pathway suppression. This finding highlights a novel mechanism and suggests new therapeutic avenues for highly aggressive and treatment-resistant thyroid cancers.

• Bestatin as a Chemical Genetic Tool in Jasmonate Signaling D

  2026-04-18

  This study demonstrates that Bestatin (Ubenimex), a selective aminopeptidase inhibitor, can specifically activate jasmonate signaling in Arabidopsis, enabling the identification of novel components in the jasmonate response pathway. The work introduces a robust chemical genetics approach for dissecting hormone-mediated defense and developmental pathways in plants.

• BMS 599626 Dihydrochloride: Precision Tools for EGFR/ErbB2 P

  2026-04-17

  Explore how BMS 599626 dihydrochloride empowers advanced EGFR and ErbB2 inhibitor research with quantitative rigor. This article uniquely bridges molecular pharmacology with data-driven assay development, offering insights not found in other resources.

• Tolazoline as an α2-Adrenergic Receptor Antagonist: Advanced

  2026-04-16

  Tolazoline stands out for its dual-action on α2-adrenergic receptors and ATP-sensitive K+ channels, enabling precise modulation in islet and airway research. This article delivers stepwise protocols, advanced troubleshooting, and practical insights to maximize Tolazoline’s value in experimental pharmacology.

• Carboplatin Resistance in Cancer Stem Cells: Mechanistic Ins

  2026-04-15

  Explore how Carboplatin, a platinum-based DNA synthesis inhibitor, interacts with cancer stem cell signaling and resistance mechanisms. This in-depth analysis reveals new translational strategies for overcoming chemoresistance in preclinical oncology research.

• Verteporfin Applications: From Photodynamic Therapy to Epige

  2026-04-14

  Verteporfin (CL 318952) redefines translational workflows by uniting light-activated vascular targeting with light-independent autophagy inhibition. Explore how APExBIO’s Verteporfin empowers robust apoptosis and chromatin studies, with practical troubleshooting and insight from recent super-enhancer research.

• Flexible Phage Nanofibers Enhance Rare Cell Capture for Canc

  2026-04-13

  This study introduces a novel affinity surface using flexible bacteriophage nanofibers functionalized with specific aptamers and tethered to magnetic beads, dramatically improving the selective isolation and profiling of rare circulating tumor cells (CTCs) from whole blood. The findings have direct implications for precise cancer subtyping and highlight how viral mechanical properties can be engineered to enhance both binding affinity and anti-fouling in clinical diagnostics.

• Optimizing Mouse Genotyping: Lysis Buffer SKU H1002 in Pract

  2026-04-13

  This article examines the scientific and operational advantages of 'Lysis buffer, components of the rapid genotyping kit for mouse tail' (SKU H1002) for mouse tissue DNA extraction. Through scenario-driven Q&A, we address common pain points in genotyping workflows and illustrate how SKU H1002 supports robust, reproducible results. Practical guidance is provided for researchers seeking reliable genomic DNA release and efficient proteinase K digestion.

• Eltanexor (KPT-8602): Reliable XPO1 Inhibition for Cancer As

  2026-04-12

  This article addresses common experimental challenges in cell viability and cytotoxicity assays, illustrating how Eltanexor (KPT-8602), SKU B8335, delivers reproducible, data-backed solutions. By exploring real laboratory scenarios, it demonstrates the practical benefits and validated performance of this second-generation XPO1 inhibitor for acute myeloid leukemia, chronic lymphocytic leukemia, and colorectal cancer research.

15547 records 1/1037 page Next 12345 下5页 Last page